Method and kit for rapidly determining patients with severe risk of death during severe sepsis and septic shock

• 1. 严重脓毒病和败血性休克期间用于快速确定死亡高风险病人的方法和试剂盒 [P] . 中国专利： CN102257387A . 2011-11-23
• 2. 早期检测败血症及检测败血症的严重程度并对败血症病程进行跟踪评估的方法，以及实现所述方法的药盒 [P] . 中国专利： CN1090928A . 1994-08-17
• 3. METHODS AND KITS FOR THE RAPID DETERMINATION OF PATIENTS AT HIGH RISK OF DEATH DURING SEVERE SEPSIS AND SEPTIC SHOCK [P] . 欧洲知识产权局专利： EP2350646B1 . 2016-01-13

  机译： 严重脓毒症和震荡发作高危死亡患者的快速测定方法和试剂盒

• 4. Methods and kits for the rapid determination of patients at high risk of death during severe sepsis and septic shock [P] . 美国专利： US8283131B2 . 2012-10-09

  机译： 快速确定严重败血症和败血性休克中高死亡风险患者的方法和试剂盒

• 5. METHODS AND KITS FOR THE RAPID DETERMINATION OF PATIENTS AT HIGH RISK OF DEATH DURING SEVERE SEPSIS AND SEPTIC SHOCK [P] . 欧洲知识产权局专利： EP2350646A1 . 2011-08-03

  机译： 严重脓毒症和震荡发作高危死亡患者的快速测定方法和试剂盒

• 1. Outcomes of severe sepsis and septic shock patients after stratifi cation by initial lactate value [J] . Kimberly A. Chambers, Adam Y. Park, Rosa C. Banuelos, 世界急诊医学杂志(英文版) . 2018,第002期
• 2. Outcomes of severe sepsis and septic shock patients after stratification by initial lactate value [J] . Kimberly A. Chambers, Adam Y. Park, Rosa C. Banuelos, 世界急诊医学杂志（英文） . 2018,第002期
• 3. Outcomes in severe sepsis and patients with septic shock do not matter! PIRO is a score to treat severe septic and septic shock patients not to measure outcomes. [J] . Rubulotta F, Ramsay G Critical care medicine . 2012,第2期
• 4. Intra-abdominal hypertension as a risk factor of death in patients with severe sepsis or septic shock [J] . A Reintam, P Parm, R Kitus, Critical care : . 2007,第Suppla2期
• 5. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S - Scandinavian Starch for Severe Sepsis/Septic Shock trial): Study protocol, design and rationale for a double-blinded, randomised clinical trial [J] . Anders Perner, Nicolai Haase, J?rn Wetterslev, Trials . 2011,第1期
• 6. Relation of heart rate variability to serum levels of C-reactive protein in patients with severe sepsis and septic shock [C] . Papaioannou V.P., Dragoumanis C.D., Pneumatikos I.P. Computers in Cardiology, 2009 . 2009
• 7. Utilizing a multi-faceted approach to improve 6-hour bundle compliance of patients with severe sepsis and septic shock [D] . Gabbard, Erika 2015
• 8. Intra-abdominal hypertension as a risk factor of death in patients with severe sepsis or septic shock [O] . A Reintam, P Parm, R Kitus, 2007
• 9. Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S - Scandinavian Starch for Severe Sepsis/Septic Shock trial): Study protocol, design and rationale for a double-blinded, randomised clinical trial [O] . Petersen John, Wiis Jørgen, Carlsson Marcela, 2011

• 1. Blood glucose control in patients with severe sepsis and septic shock [J] . Hiroyuki Hirasawa ,Shigeto Oda ,Masataka Nakamura . 世界胃肠病学杂志：英文版 . 2009,第33期
• 2. Severe sepsis and septic shock in the elderly:An overview [J] . Prashant Nasa1 ,Deven Juneja1 ,Omender Singh1 . 世界重症医学杂志 . 2012,第001期
• 3. Severe insulin resistance treatment with intravenous chromium in septic shock patient [J] . Salim R Surani ,Iqbal Ratnani ,Bharath Guntupalli . 世界糖尿病杂志：英文版（电子版） . 2012,第9期
• 4. 严重败血症及败血症休克的抗菌药物治疗 [C] . Wang Longfei ,王龙飞 ,Li lin . 2014年西南药学大会 . 2014
• 5. 重庆市严重胸部创伤流行趋势、死亡危险因素及基因背景与严重并发症易感性的相关研究 [A] . 刘云 . 2011